Model
Edge
BioCryst Pharmaceuticals Inc
0001800110
Filing Type
4
Filing Date
12/20/2022
Updated
12/21/22, 9:34 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership